SAVANNAH, GEORGIA — Remote monitoring of respiratory scores in patients with amyotrophic ... a systematic review of 26 papers on ALS remote assessment devices and methods, including ...

The first patient has been dosed in a Phase 1/2 clinical trial of AMT-162, the one-time gene therapy in development by uniQure for treating amyotrophic lateral sclerosis (ALS) caused by mutations in ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative condition affecting the brain, spinal cord, and muscle activity. ALS Support Groups for Patients and ...

Inhibiting these enzymes should reduce inflammation and protect nerve cells from damage in ALS, slowing disease progression. Applications submitted to EMA and Health Canada were supported by data from ...

The locally produced ‘Arm Booster’ is 10 times cheaper and can be used to rehabilitate stroke patients in remote areas, says professor Thammasat University has developed a device to help stroke ...

Diana Zuckerman, president of the National Center for Health Research, a nonprofit that tracks F.D.A. device policy, said she had found Dr. Tarver to be concerned about patient safety and “in ...

7NEWS Sports presents the High School Red Zone with Pete Yanity. Read more: https://www.wspa.com/sports/high-school-football/scores-high-school-red-zone-week-9-5 ...

“Time is of the essence. It’s really important because the paradigm of looking at ALS is shifting from this being a fatal disease that nobody can do anything about,” said Suma Babu ...

HE WAS DIAGNOSED WITH ALS. ALSO KNOWN AS LOU GEHRIG’S DISEASE. THERE’S NO CURE FOR IT, AND A LOT OF PEOPLE HAVE BEEN GETTING IT AND IT’S JUST HAVING NO EDUCATION ON IT. IT SCARES PEOPLE ...

Employers value communication skills since they foster collaboration, build trust and create solid client relationships. Communication skills to showcase on your resume include storytelling ...

SOD1-ALS is a devastating form of the disease that progresses quickly and is invariably fatal, affecting around 330 people in the US. Qalsody has been approved based on its ability to reduce ...

It identifies six key areas that present challenges to spoken communication. Every 36 hours the NHS deals with over a million patients and each of these contacts probably generates discussion between ...